DuChemBio Co (XKRX:176750) Debt-to-Revenue : 0.63 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

DuChemBio Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩14,726 Mil. DuChemBio Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩7,030 Mil. DuChemBio Co's annualized Revenue for the quarter that ended in Dec. 2023 was ₩34,695 Mil. DuChemBio Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.63.

DuChemBio Co Debt-to-Revenue Historical Data

The historical data trend for DuChemBio Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Debt-to-Revenue Chart

DuChemBio Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

1.25

1.33

2.92

0.84

0.63

DuChemBio Co Semi-Annual Data
	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial			1.25	1.33	2.92	0.84	0.63

Competitive Comparison of DuChemBio Co's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, DuChemBio Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DuChemBio Co's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DuChemBio Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where DuChemBio Co's Debt-to-Revenue falls into.

DuChemBio Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

DuChemBio Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(14725.659	+	7029.692)	/	34695.49
	=	0.63

DuChemBio Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(14725.659	+	7029.692)	/	34695.49
	=	0.63

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (Dec. 2023) Revenue data.

DuChemBio Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

DuChemBio Co (XKRX:176750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Debt-to-Revenue

Traded in Other Exchanges

N/A

Address

Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3

Website

http://www.duchembio.com

DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines